Memorial Sloan Kettering Cancer Center, New York, NY, United States of America.
J Radiol Prot. 2024 Feb 26;44(1). doi: 10.1088/1361-6498/ad246a.
Radioactive seed localization (RSL) provides a precise and efficient method for removing non-palpable breast lesions. It has proven to be a valuable addition to breast surgery, improving perioperative logistics and patient satisfaction. This retrospective review examines the lessons learned from a high-volume cancer center's RSL program after 10 years of practice and over 25 000 cases. We provide an updated model for assessing the patient's radiation dose from RSL seed implantation and demonstrate the safety of RSL to staff members. Additionally, we emphasize the importance of various aspects of presurgical evaluation, surgical techniques, post-surgical management, and regulatory compliance for a successful RSL program. Notably, the program has reduced radiation exposure for patients and medical staff.
放射性粒子定位（RSL）为切除不可触及的乳腺病变提供了一种精确且高效的方法。它已被证明是乳腺外科的一项重要补充，改善了围手术期的物流管理和患者满意度。本回顾性研究对一家大容量癌症中心的 RSL 项目在 10 年的实践和超过 25000 例病例后所获得的经验教训进行了探讨。我们提供了一种用于评估 RSL 种子植入患者辐射剂量的更新模型，并证明了 RSL 对工作人员的安全性。此外，我们强调了术前评估、手术技术、术后管理和监管合规性等各个方面对于 RSL 项目成功的重要性。值得注意的是，该项目降低了患者和医务人员的辐射暴露。
